Recently updated USP standards and how they impact compounding medicines for veterinary practitioners
In the veterinary industry, the recent United States Pharmacopeia (USP) updates pose the question: How will compounding medicines be affected?
In this episode, Marcy A. Bliss and Anthony Grzib, R.Ph., share their insights surrounding the USP revisions and how they may affect veterinarians, including the basics of the updated practice standards highlighted in USP General Chapters <795> and <797>.
Below is a partial transcript. Listen to the podcast above for more.
Anthony Grzib, R.Ph.: “USP [bases its] standards on science and evidence. For the most part, these standards in the revised chapters are more rigorous than we’ve seen in the past…The two areas that I think are the most impactful to both pharmacies and veterinarians have to do with the assigning of beyond-use dates.”